Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jan;66(1):130-1.
doi: 10.1136/ard.2006.059758.

Thrombocytopenia in lupus: baseline C3 as an independent risk factor for relapse

P D Ziakas, L S Poulou, S Giannouli, A G Tzioufas, M Voulgarelis

Thrombocytopenia in lupus: baseline C3 as an independent risk factor for relapse

P D Ziakas et al. Ann Rheum Dis. 2007 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Arnal C, Piette J C, Leone J, Taillan B, Hachulla E, Roudot‐Thoraval F.et al Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases. J Rheumatol 20022975–83. - PubMed
    1. Boumpas D T, Barez S, Klippel J H, Balow J E. Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus. Ann Intern Med 1990112674–677. - PubMed
    1. Avina‐Zubieta J A, Galindo‐Rodriguez G, Robledo I, Vela‐Ojeda J, Vadillo‐Buenfil M, Rosas‐Cabral A.et al Long‐term effectiveness of danazol corticosteroids and cytotoxic drugs in the treatment of hematologic manifestations of systemic lupus erythematosus. Lupus 20031252–57. - PubMed
    1. Kneitz C, Wilhelm M, Tony H P. Effective B cell depletion with rituximab in the treatment of autoimmune diseases. Immunobiology 2002206519–527. - PubMed
    1. Vasoo S, Thumboo J, Fong K Y. Refractory immune thrombocytopenia in systemic lupus erythematosus: response to mycophenolate mofetil. Lupus 200312630–632. - PubMed